AP18621b-ev
|
Abcepta, Inc.
|
SMN1 [C-term] [RB39548], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
AP18621b
|
Abcepta, Inc.
|
SMN1 [C-term] [RB39548], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
ATGP2814-100ug
|
NKMax Bio (ATGen)
|
CHCHD7 [1-97 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
ATGP2814-20ug
|
NKMax Bio (ATGen)
|
CHCHD7 [1-97 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
ATGP2014-100ug
|
NKMax Bio (ATGen)
|
SERPING1 [23-500 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE, Denatured
|
|
ATGP2014-500ug
|
NKMax Bio (ATGen)
|
SERPING1 [23-500 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE, Denatured
|
|
ATGP3829-250ug
|
NKMax Bio (ATGen)
|
SERPING1 [23-500 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
ATGP3829-50ug
|
NKMax Bio (ATGen)
|
SERPING1 [23-500 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
GTX11085
|
GeneTex International Corporation
|
Myosin skeletal + smooth, Rabbit Polyclonal Antibody
|
Human
|
ICC/IF
|
|
HY-101359-10mg
|
MedChemexpress LLC
|
TPMPA [CAS 182485-36-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-10182-10mg
|
MedChemexpress LLC
|
Laduviglusib [CAS 252917-06-9]
|
|
Cancer-Kinase/protease
|
|
HY-10182-100mg
|
MedChemexpress LLC
|
Laduviglusib [CAS 252917-06-9]
|
|
Cancer-Kinase/protease
|
|
HY-10182-200mg
|
MedChemexpress LLC
|
Laduviglusib [CAS 252917-06-9]
|
|
Cancer-Kinase/protease
|
|
HY-10182-5mg
|
MedChemexpress LLC
|
Laduviglusib [CAS 252917-06-9]
|
|
Cancer-Kinase/protease
|
|
HY-10182-50mg
|
MedChemexpress LLC
|
Laduviglusib [CAS 252917-06-9]
|
|
Cancer-Kinase/protease
|
|
HY-10182A-10mg
|
MedChemexpress LLC
|
Laduviglusib (monohydrochloride) [CAS 1797989-42-4]
|
|
Cancer-Kinase/protease
|
|
HY-10182A-100mg
|
MedChemexpress LLC
|
Laduviglusib (monohydrochloride) [CAS 1797989-42-4]
|
|
Cancer-Kinase/protease
|
|
HY-10182A-5mg
|
MedChemexpress LLC
|
Laduviglusib (monohydrochloride) [CAS 1797989-42-4]
|
|
Cancer-Kinase/protease
|
|
HY-10182A-50mg
|
MedChemexpress LLC
|
Laduviglusib (monohydrochloride) [CAS 1797989-42-4]
|
|
Cancer-Kinase/protease
|
|
HY-10182B-10mg
|
MedChemexpress LLC
|
Laduviglusib (trihydrochloride) [CAS 1782235-14-6]
|
|
Cancer-Kinase/protease
|
|
HY-10182B-5mg
|
MedChemexpress LLC
|
Laduviglusib (trihydrochloride) [CAS 1782235-14-6]
|
|
Cancer-Kinase/protease
|
|
HY-10182B-50mg
|
MedChemexpress LLC
|
Laduviglusib (trihydrochloride) [CAS 1782235-14-6]
|
|
Cancer-Kinase/protease
|
|
HY-10256-10mg
|
MedChemexpress LLC
|
Adezmapimod [CAS 152121-47-6]
|
|
COVID-19-immunoregulation
|
|
HY-10256-100mg
|
MedChemexpress LLC
|
Adezmapimod [CAS 152121-47-6]
|
|
COVID-19-immunoregulation
|
|
HY-10256-5mg
|
MedChemexpress LLC
|
Adezmapimod [CAS 152121-47-6]
|
|
COVID-19-immunoregulation
|
|